3Greene FL,Compton CC,Fritz AG,et al. AJCC cancer staging atlas. 6th ed. New York: Springer-Verlag,2006.
4Kronberg U, Lo'pez Kostner F, Soto G, et al. Detection of lymphatic micrometastases in patients with stages Ⅰ and Ⅱ colorectal cancer: Impact on five-year survival. Dis Colon Rectum, 2004, 47: 1151-1157.
5Fleming FJ, Hayanga AJ, Glynn F, et al. Incidence and prognostic influence of lymph node micrometastases in rectal cancer. Eur J Surg Oncol, 2007,33 : 998-1002.
6Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma : An immunohistochemical by CAMS. 2. Clin Cancer Res, 1999, 5: 2065-2068.
7Turner RR, Nora DT, Trocha SD. et al. Colorectal carcinoma' nodal staging frequency and nature of cytokeratinpositive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med, 2000,127: 673-679.
8Hermanek P, Hutter RV, Sobin LH, et. al. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer, 1999, 86: 2668-2673.
9Rosenberg R, Hoos A, Mueller J, et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J ClinOncol, 2002,20: 1049-1055.
10Lee MR, Hong CW, Yoon SN, et. al. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage Ⅱ colorectal cancer. J Surg Oncol, 2006,93: 13-8; discussion 18-19.
2Leuenberge M, Kurmann S, Stanga Z. Nutritional screening tools in daily clinical practice: the focus on cancer[J]. Support Care Cancer, 2010, 18(2):S17-S27.
3Lochs H, Allison SP, Meier R, et al. Introductory to the ESPEN guidelines in enternal nutrition: terminology, definitions and general topics[J]. Clin Nutr, 2006, 25(2) : 180-186.
4Michèle Leuenberger,Silvia Kurmann,Zeno Stanga.Nutritional screening tools in daily clinical practice: the focus on cancer[J]Supportive Care in Cancer,2010(2).
